Synthetic Lipid Second Messenger sn-1,2-Didecanoylglycerol

A Complete Tumor Promoter in Mouse Skin

Robert C. Smart, Kevin J. Mills, Laura A. Hansen, Allan H. Conney

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

sn-l,2-DidecanoylglyceroI, a synthetic lipid second messenger and model diacylglycerol, was evaluated as a complete skin tumor promoter in CD-I mice. In addition, sn-1,2-dioctanoylglycerol, sn-l,2-didecanoylglycerol, the second stage tumor promoter mezerein, and the complete tumor promoter 12-0-tetradecanoylphorbol-13-acetate (TPA) were examined for their ability to stimulate epidermal protein kinase C activity in vitro. All four compounds stimulated epidermal protein kinase C activity utilizing lysine-rich histone as the phosphate acceptor substrate. sn-l,2-Dioctanoylglycerol and sn-1,2-didecanoylglycerol stimulated epidermal protein kinase C activity to a maximum velocity similar to that obtained when the enzyme was stimulated with TPA; however, about 1000 times greater concentration of the sn-1,2-diacylglycerols was required. sn-l,2-Didecanoylglycerol was evaluated as a complete skin tumor promoter in CD-I mice utilizing a dosing regimen demonstrated to produce epidermal hyperplasia. Mice were initiated with 200 nmol 7,12-dimethylbenz[a]anthracene. One week later the mice received twice daily topical applications of 1 nmol TPA, 2 μmol sn -l,2-didecanoylglycerol or 5 μmol sn-l,2-didecanoylglycerol, 5 days/week. Additional initiated mice received twice weekly topical applications of 2 or 5 nmol TPA. Initiated mice treated with 5 nmol TPA twice weekly or with 1 μmol TPA twice daily for 5 days/week (cumulative weekly doses of 10 nmol TPA) responded similarly, based on the tumor incidence and the average number of tumors per mouse. Initiated mice treated with 2 or 5 μmol sn-1,2-didecanoylglycerol twice daily developed tumors in a dose-dependent manner. Initiated mice treated with 5 μmol sn-l,2-didecanoylglycerol twice daily developed many tumors, and at 20 weeks there was a 74% tumor incidence and an average of 6.0 tumors/mouse. At 20 weeks, 24% of the initiated mice treated with 2 μmol sn-l,2-didecanoylglycerol twice daily developed tumors, with an average of 1.1 tumors/mouse. Mice which were not initiated but treated twice daily with 5 Amol sn-1,2-didecanoylglycerol for 20 weeks did not develop any tumors. These data demonstrate that the representative synthetic lipid second messenger sn-1,2-didecanoylglycerol, like TPA, is a complete tumor promoter in DMBA-initiated mouse skin.

Original languageEnglish
Pages (from-to)4455-4458
Number of pages4
JournalCancer Research
Volume49
Issue number16
StatePublished - Aug 1 1989
Externally publishedYes

Fingerprint

Second Messenger Systems
Carcinogens
Lipids
Skin
Tetradecanoylphorbol Acetate
Neoplasms
CD-I
Protein Kinase C
1,2-didecanoylglycerol
9,10-Dimethyl-1,2-benzanthracene
Diglycerides
Incidence
Histones
Lysine
Hyperplasia

All Science Journal Classification (ASJC) codes

  • Cancer Research
  • Oncology

Cite this

Synthetic Lipid Second Messenger sn-1,2-Didecanoylglycerol : A Complete Tumor Promoter in Mouse Skin. / Smart, Robert C.; Mills, Kevin J.; Hansen, Laura A.; Conney, Allan H.

In: Cancer Research, Vol. 49, No. 16, 01.08.1989, p. 4455-4458.

Research output: Contribution to journalArticle

Smart, Robert C. ; Mills, Kevin J. ; Hansen, Laura A. ; Conney, Allan H. / Synthetic Lipid Second Messenger sn-1,2-Didecanoylglycerol : A Complete Tumor Promoter in Mouse Skin. In: Cancer Research. 1989 ; Vol. 49, No. 16. pp. 4455-4458.
@article{46a2a039ff1f4ff3b15cd9409b834fdc,
title = "Synthetic Lipid Second Messenger sn-1,2-Didecanoylglycerol: A Complete Tumor Promoter in Mouse Skin",
abstract = "sn-l,2-DidecanoylglyceroI, a synthetic lipid second messenger and model diacylglycerol, was evaluated as a complete skin tumor promoter in CD-I mice. In addition, sn-1,2-dioctanoylglycerol, sn-l,2-didecanoylglycerol, the second stage tumor promoter mezerein, and the complete tumor promoter 12-0-tetradecanoylphorbol-13-acetate (TPA) were examined for their ability to stimulate epidermal protein kinase C activity in vitro. All four compounds stimulated epidermal protein kinase C activity utilizing lysine-rich histone as the phosphate acceptor substrate. sn-l,2-Dioctanoylglycerol and sn-1,2-didecanoylglycerol stimulated epidermal protein kinase C activity to a maximum velocity similar to that obtained when the enzyme was stimulated with TPA; however, about 1000 times greater concentration of the sn-1,2-diacylglycerols was required. sn-l,2-Didecanoylglycerol was evaluated as a complete skin tumor promoter in CD-I mice utilizing a dosing regimen demonstrated to produce epidermal hyperplasia. Mice were initiated with 200 nmol 7,12-dimethylbenz[a]anthracene. One week later the mice received twice daily topical applications of 1 nmol TPA, 2 μmol sn -l,2-didecanoylglycerol or 5 μmol sn-l,2-didecanoylglycerol, 5 days/week. Additional initiated mice received twice weekly topical applications of 2 or 5 nmol TPA. Initiated mice treated with 5 nmol TPA twice weekly or with 1 μmol TPA twice daily for 5 days/week (cumulative weekly doses of 10 nmol TPA) responded similarly, based on the tumor incidence and the average number of tumors per mouse. Initiated mice treated with 2 or 5 μmol sn-1,2-didecanoylglycerol twice daily developed tumors in a dose-dependent manner. Initiated mice treated with 5 μmol sn-l,2-didecanoylglycerol twice daily developed many tumors, and at 20 weeks there was a 74{\%} tumor incidence and an average of 6.0 tumors/mouse. At 20 weeks, 24{\%} of the initiated mice treated with 2 μmol sn-l,2-didecanoylglycerol twice daily developed tumors, with an average of 1.1 tumors/mouse. Mice which were not initiated but treated twice daily with 5 Amol sn-1,2-didecanoylglycerol for 20 weeks did not develop any tumors. These data demonstrate that the representative synthetic lipid second messenger sn-1,2-didecanoylglycerol, like TPA, is a complete tumor promoter in DMBA-initiated mouse skin.",
author = "Smart, {Robert C.} and Mills, {Kevin J.} and Hansen, {Laura A.} and Conney, {Allan H.}",
year = "1989",
month = "8",
day = "1",
language = "English",
volume = "49",
pages = "4455--4458",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "16",

}

TY - JOUR

T1 - Synthetic Lipid Second Messenger sn-1,2-Didecanoylglycerol

T2 - A Complete Tumor Promoter in Mouse Skin

AU - Smart, Robert C.

AU - Mills, Kevin J.

AU - Hansen, Laura A.

AU - Conney, Allan H.

PY - 1989/8/1

Y1 - 1989/8/1

N2 - sn-l,2-DidecanoylglyceroI, a synthetic lipid second messenger and model diacylglycerol, was evaluated as a complete skin tumor promoter in CD-I mice. In addition, sn-1,2-dioctanoylglycerol, sn-l,2-didecanoylglycerol, the second stage tumor promoter mezerein, and the complete tumor promoter 12-0-tetradecanoylphorbol-13-acetate (TPA) were examined for their ability to stimulate epidermal protein kinase C activity in vitro. All four compounds stimulated epidermal protein kinase C activity utilizing lysine-rich histone as the phosphate acceptor substrate. sn-l,2-Dioctanoylglycerol and sn-1,2-didecanoylglycerol stimulated epidermal protein kinase C activity to a maximum velocity similar to that obtained when the enzyme was stimulated with TPA; however, about 1000 times greater concentration of the sn-1,2-diacylglycerols was required. sn-l,2-Didecanoylglycerol was evaluated as a complete skin tumor promoter in CD-I mice utilizing a dosing regimen demonstrated to produce epidermal hyperplasia. Mice were initiated with 200 nmol 7,12-dimethylbenz[a]anthracene. One week later the mice received twice daily topical applications of 1 nmol TPA, 2 μmol sn -l,2-didecanoylglycerol or 5 μmol sn-l,2-didecanoylglycerol, 5 days/week. Additional initiated mice received twice weekly topical applications of 2 or 5 nmol TPA. Initiated mice treated with 5 nmol TPA twice weekly or with 1 μmol TPA twice daily for 5 days/week (cumulative weekly doses of 10 nmol TPA) responded similarly, based on the tumor incidence and the average number of tumors per mouse. Initiated mice treated with 2 or 5 μmol sn-1,2-didecanoylglycerol twice daily developed tumors in a dose-dependent manner. Initiated mice treated with 5 μmol sn-l,2-didecanoylglycerol twice daily developed many tumors, and at 20 weeks there was a 74% tumor incidence and an average of 6.0 tumors/mouse. At 20 weeks, 24% of the initiated mice treated with 2 μmol sn-l,2-didecanoylglycerol twice daily developed tumors, with an average of 1.1 tumors/mouse. Mice which were not initiated but treated twice daily with 5 Amol sn-1,2-didecanoylglycerol for 20 weeks did not develop any tumors. These data demonstrate that the representative synthetic lipid second messenger sn-1,2-didecanoylglycerol, like TPA, is a complete tumor promoter in DMBA-initiated mouse skin.

AB - sn-l,2-DidecanoylglyceroI, a synthetic lipid second messenger and model diacylglycerol, was evaluated as a complete skin tumor promoter in CD-I mice. In addition, sn-1,2-dioctanoylglycerol, sn-l,2-didecanoylglycerol, the second stage tumor promoter mezerein, and the complete tumor promoter 12-0-tetradecanoylphorbol-13-acetate (TPA) were examined for their ability to stimulate epidermal protein kinase C activity in vitro. All four compounds stimulated epidermal protein kinase C activity utilizing lysine-rich histone as the phosphate acceptor substrate. sn-l,2-Dioctanoylglycerol and sn-1,2-didecanoylglycerol stimulated epidermal protein kinase C activity to a maximum velocity similar to that obtained when the enzyme was stimulated with TPA; however, about 1000 times greater concentration of the sn-1,2-diacylglycerols was required. sn-l,2-Didecanoylglycerol was evaluated as a complete skin tumor promoter in CD-I mice utilizing a dosing regimen demonstrated to produce epidermal hyperplasia. Mice were initiated with 200 nmol 7,12-dimethylbenz[a]anthracene. One week later the mice received twice daily topical applications of 1 nmol TPA, 2 μmol sn -l,2-didecanoylglycerol or 5 μmol sn-l,2-didecanoylglycerol, 5 days/week. Additional initiated mice received twice weekly topical applications of 2 or 5 nmol TPA. Initiated mice treated with 5 nmol TPA twice weekly or with 1 μmol TPA twice daily for 5 days/week (cumulative weekly doses of 10 nmol TPA) responded similarly, based on the tumor incidence and the average number of tumors per mouse. Initiated mice treated with 2 or 5 μmol sn-1,2-didecanoylglycerol twice daily developed tumors in a dose-dependent manner. Initiated mice treated with 5 μmol sn-l,2-didecanoylglycerol twice daily developed many tumors, and at 20 weeks there was a 74% tumor incidence and an average of 6.0 tumors/mouse. At 20 weeks, 24% of the initiated mice treated with 2 μmol sn-l,2-didecanoylglycerol twice daily developed tumors, with an average of 1.1 tumors/mouse. Mice which were not initiated but treated twice daily with 5 Amol sn-1,2-didecanoylglycerol for 20 weeks did not develop any tumors. These data demonstrate that the representative synthetic lipid second messenger sn-1,2-didecanoylglycerol, like TPA, is a complete tumor promoter in DMBA-initiated mouse skin.

UR - http://www.scopus.com/inward/record.url?scp=0024410008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024410008&partnerID=8YFLogxK

M3 - Article

VL - 49

SP - 4455

EP - 4458

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 16

ER -